Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Axsome Therapeutics, Inc.(AXSM) | 2,360,077 | 2,360,077 | 0 | $187.84M | $188.33M | 20.53% | +$495.6K |
| Nuvalent Inc | 1,924,626 | 1,924,626 | 0 | $141.63M | $144.52M | 15.75% | +$2.89M |
| Apogee Therapeutics Inc | 2,941,176 | 2,048,647 | -892,529 | $82.18M | $136.13M | 14.84% | +$53.96M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,928,503 | 2,762,837 | +834,334 | $20.06M | $82.89M | 9.03% | +$62.83M |
| Kiniksa Pharmaceuticals LtdCL A | 2,883,221 | 3,204,841 | +321,620 | $50.57M | $63.23M | 6.89% | +$12.66M |
| Enliven Therapeutics Inc | 2,131,369 | 3,202,798 | +1,071,429 | $29.50M | $56.34M | 6.14% | +$26.84M |
| Astria Therapeutics Inc | 3,554,129 | 3,554,129 | 0 | $27.30M | $50.02M | 5.45% | +$22.73M |
| Viridian Therapeutics, Inc.(VRDN) | 1,369,623 | 1,845,813 | +476,190 | $29.83M | $32.32M | 3.52% | +$2.49M |
| Merus N V | 717,254 | 717,254 | 0 | $19.72M | $32.30M | 3.52% | +$12.57M |
| Cogent Biosciences, Inc.(COGT) | 3,558,975 | 4,725,641 | +1,166,666 | $20.93M | $31.76M | 3.46% | +$10.83M |
| Protagonist Therapeutics Inc | 0 | 931,890 | +931,890 | $0 | $26.96M | 2.94% | +$26.96M |
| Tyra Biosciences, Inc.(TYRA) | 1,393,329 | 1,393,329 | 0 | $19.30M | $22.85M | 2.49% | +$3.55M |
| Geron Corporation(GERN) | 0 | 6,666,667 | +6,666,667 | $0 | $22.00M | 2.40% | +$22.00M |
| Spyre Therapeutics, Inc.(SYRE) | 378,421 | 378,421 | 0 | $8.14M | $14.35M | 1.56% | +$6.21M |
| Terns Pharmaceuticals Inc | 2,040,000 | 2,040,000 | 0 | $13.24M | $13.38M | 1.46% | +$142.8K |
| argenx SEADR(ARGX) | 112,903 | 0 | -112,903 | $42.95M | $0 | — | -$42.95M |
| Immunogen Inc | 5,929,592 | 0 | -5,929,592 | $175.81M | $0 | — | -$175.81M |
| Rayzebio Inc | 1,245,929 | 0 | -1,245,929 | $77.46M | $0 | — | -$77.46M |